Maurizio Fermeglia
TitleCited byYear
Extraction technologies for medicinal and aromatic plants
United Nations Industrial Development Organization, SS Handa, ...
Earth, Environmental and Marine Sciences and Technologies, 2008
Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance
T Wei, C Chen, J Liu, C Liu, P Posocco, X Liu, Q Cheng, S Huo, Z Liang, ...
Proceedings of the National Academy of Sciences 112 (10), 2978-2983, 2015
Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates
SE Woodman, JC Trent, K Stemke-Hale, AJ Lazar, S Pricl, GM Pavan, ...
Molecular cancer therapeutics 8 (8), 2079-2085, 2009
Unifac prediction of vapor—liquid equilibria in mixed solvent—salt systems
I Kikic, M Fermeglia, P Rasmussen
Chemical Engineering Science 46 (11), 2775-2780, 1991
Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1, 3, 4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modeling investigations
MG Mamolo, D Zampieri, L Vio, M Fermeglia, M Ferrone, S Pricl, ...
Bioorganic & medicinal chemistry 13 (11), 3797-3809, 2005
Polymer− clay nanocomposites: a multiscale molecular modeling approach
G Scocchi, P Posocco, M Fermeglia, S Pricl
The Journal of Physical Chemistry B 111 (9), 2143-2151, 2007
Sodium montmorillonite silylation: Unexpected effect of the aminosilane chain length
F Piscitelli, P Posocco, R Toth, M Fermeglia, S Pricl, G Mensitieri, ...
Journal of Colloid and Interface Science 351 (1), 108-115, 2010
Multiscale modeling for polymer systems of industrial interest
M Fermeglia, S Pricl
Progress in Organic Coatings 58 (2-3), 187-199, 2007
Excess volumes and viscosities of binary mixtures of organics
M Fermeglia, R Lapasin
Journal of Chemical and Engineering Data 33 (4), 415-417, 1988
Hydrogen sulphide removal from biogas by zeolite adsorption: Part I. GCMC molecular simulations
P Cosoli, M Ferrone, S Pricl, M Fermeglia
Chemical Engineering Journal 145 (1), 86-92, 2008
Computer simulation of polypropylene/organoclay nanocomposites: characterization of atomic scale structure and prediction of binding energy
R Toth, A Coslanich, M Ferrone, M Fermeglia, S Pricl, S Miertus, ...
Polymer 45 (23), 8075-8083, 2004
Adaptive amphiphilic dendrimer‐based nanoassemblies as robust and versatile siRNA delivery systems
X Liu, J Zhou, T Yu, C Chen, Q Cheng, K Sengupta, Y Huang, H Li, C Liu, ...
Angewandte Chemie International Edition 53 (44), 11822-11827, 2014
Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients
E Tamborini, S Pricl, T Negri, MS Lagonigro, F Miselli, A Greco, A Gronchi, ...
Oncogene 25 (45), 6140, 2006
Computer simulation of nylon-6/organoclay nanocomposites: prediction of the binding energy
M Fermeglia, M Ferrone, S Pricl
Fluid Phase Equilibria 212 (1-2), 315-329, 2003
Density, viscosity, and refractive index for binary systems of n-C16 and four nonlinear alkanes at 298.15 K
M Fermeglia, G Torriano
Journal of Chemical & Engineering Data 44 (5), 965-969, 1999
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
S Pricl, B Cortelazzi, V Dal Col, D Marson, E Laurini, M Fermeglia, ...
Molecular oncology 9 (2), 389-397, 2015
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach
E Banfi, G Scialino, D Zampieri, MG Mamolo, L Vio, M Ferrone, ...
Journal of Antimicrobial Chemotherapy 58 (1), 76-84, 2006
Synthesis and physicochemical characterization of folate− cyclodextrin bioconjugate for active drug delivery
P Caliceti, S Salmaso, A Semenzato, T Carofiglio, R Fornasier, ...
Bioconjugate chemistry 14 (5), 899-908, 2003
Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for σ1 receptor ligands based on a series of substituted benzo [d] oxazol-2 (3 H)-oneá…
D Zampieri, MG Mamolo, E Laurini, C Florio, C Zanette, M Fermeglia, ...
Journal of medicinal chemistry 52 (17), 5380-5393, 2009
T315I-mutated Bcr-Abl in chronic myeloid leukemia and imatinib: insights from a computational study
S Pricl, M Fermeglia, M Ferrone, E Tamborini
Molecular cancer therapeutics 4 (8), 1167-1174, 2005
The system can't perform the operation now. Try again later.
Articles 1–20